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Tyrosylprotein sulfotransferase (TPST), the enzyme responsible for the sulfation of tyrosine residues, has been identified 
and characterized in submandibular salivary glands previously (William et al. Arch Biochem Biophys 338: 90-96). 
Tyrosylprotein sulfotransferase catalyses the sulfation of a variety of secretory and membrane proteins and is believed 
to be present only in the cell. In the present study, this enzyme was identified for the first time in human saliva. 
Analysis of human saliva and parotid saliva for the presence of tyrosylprotein sulfotransferase revealed tyrosine 
sulfating activity displayed by both whole saliva and parotid saliva at pH optimum of 6.8. In contrast to tyrosylprotein 
sulfotransferase isolated from submandibular salivary glands, salivary enzyme does not require the presence of Triton 
X-100, NaF and 5’AMP for maximal activity. Similar to the submandibular TPST, the enzyme from saliva also required 
MnCl2 for its activity. Maximum TPST activity was observed at 20mM MnCl2. The enzyme from saliva was 
immunoprecipitated and purified by immunoaffinity column using anti-TPST antibody. Affinity purified salivary TPST 
showed a single band of 50-54 kDa. This study is the first report characterizing a tyrosylprotein sulfotransferase in a 
secretory fluid. 
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1.  Introduction 
Tyrosine sulfation, a posttranslational modification 
involved in the processing of secretory proteins, is the 
covalent attachment of sulfate to the hydroxyl group of 
the tyrosyl residues in peptides and proteins. O-sulfation 
of the tyrosine residues has been the subject of several 
studies on the posttranslational modification of proteins 
[2]. This modification occurs in the trans-Golgi, the 
compartment involved in the maturation and sorting of 
secretory proteins and peptides including cholecystokinin 
[3], fibrinopeptide B [4], gastrin [5] phyllokinin [6], 
leucosulfakinin [7], C4 complement [8], hirudin [9], P-
selectin glycoprotein ligand-1 (PSGL-1) [10] and 
chemokine receptor CCR5 [11]. Tyrosine sulfation in these 
proteins has been suggested to be essential for their 
biological activity, half-life, and secretion. Sulfation of 
tyrosyl residues in cholecystokinin is required for its 
optimal biological activity [12] and in the case of hirudin, 
tyrosine sulfation increases the binding efficiency to 
thrombin [9]. In M31 hybridoma cell line, tyrosine 
sulfation has been shown to serve as a signal for the 
secretion of IgG [13]. In PSGL-1, tyrosine sulfation is 
required for its binding to p-selectin [10] and the tyrosine 
sulfation of CCR5 facilitates HIV-1 entry [11]. Although 
the significance of tyrosine sulfation in these and several 
other proteins has been studied in detail, its role in 
salivary protein is yet to be investigated. 
Tyrosylprotein sulfotransferase has been identified in 
numerous tissues including bovine adrenal medulla [14], 
rat liver [15], brain [16], gastric mucosa [17], 
submandibular salivary glands [18] and platelets [19]. In 
this study, we demonstrate for the first time the detection, 
isolation and characterization of TPST from human saliva.  
2.  Materials and methods  
Materials 
 [35S]PAPS (2 Ci/mmol) was from DuPont New 
England Nuclear, EAY (Mr 47 kDa), 5'-AMP were from 
Sigma-Aldrich. All other reagents were of analytical 
grade. 
Collection of Saliva 
Human Saliva 
Unstimulated saliva was obtained from healthy 
individuals. The saliva was centrifuged at 6,000 RPM for 
30 min and the clear supernatant was separated from 
sediment containing food particles. 
Parotid Saliva 
Parotid saliva was collected as described in [20]. 
Parotid salivary flow was stimulated by means of 
confectionary which contained citric acid and tartaric acid. 
The saliva sample of about 10 ml was collected from 
parotid salivary glands by means of special devices. 
Protein concentration was estimated by the BCA protein 
assay reagent kit (Pierce chemical Co). Optimally diluted 
saliva samples were used for the tyrosylprotein 
sulfotransferase activity. 
Assay of tyrosylprotein sulfotransferase 
The tyrosylprotein sulfotransferase assay mixture 
contained the following components: acceptor, unsulfated 
EAY at concentrations indicated in text, 5 µM [35S]PAPS 
(400,000 cpm), 20 mM MnCl2, 20 mM MES buffer pH 6.8 
and saliva (50 µg protein) in a final volume of 50 µl. 
Assays were initiated by the addition of the enzyme and 
incubated for 30 min at 37°C. The reactions were stopped Int. J. Biol. Sci. 2005 1  142
by spotting 35 µl aliquot of the reaction mixture on a 2.4 x 
2.4 cm Whatman No. 3MM filter paper [15]. The papers 
were washed three times for 15 min in 10% trichloroacetic 
acid/10 mM Na2SO4 and rinsed 5 min in 95% ethanol. The 
dried papers were placed in vials containing scintillation 
solution and counted in a TriCarb-1500 scintillation 
counter.  
SDS-Polyacrylamide Gel Electrophoresis 
Proteins were separated by electrophoresis by the 
method of Laemml [21]. The separating gels contained 
10% (w/v) acrylamide, bis(acrylamide) in the ratio of 
37.5:1, 0.375 M Tris-HCl, pH 8.8, 0.1% SDS, 0.026% 
TEMED, and 0.026% ammonium persulfate. The stacking 
gel contained 3% acrylamide, bis(acrylamide) in the same 
ratio as before, 0.125 M Tris-HCl, pH 6.8, 0.1% SDS, 0.05% 
ammonium persulfate, and 0.4% TEMED. Electrophoresis 
was performed in a Mighty Small gel apparatus (Hoefer 
Scientific Instruments, San Francisco, CA) at 4°C at a 
constant current of 20 mA per gel for approximately 1 h. 
Protein bands on the gels were visualized by silver 
staining. 
Immunoblot Procedure 
P r o t e i n s  w e r e  r e s o l v e d  b y  S D S - P A G E  o n  a  1 0 %  
polyacrylamide gel and electrophoretically transferred (20 
V for 20 min) to a nitrocellulose membrane (Millipore) by 
means of a Bio-Rad Semi Dry Transblot apparatus 
according to the procedure supplied by the Bio-Rad. The 
section of the nitrocellulose membrane containing the 
molecular weight standards was cut off and stained with 
Ponceau S in 45% methanol and 10% acetic acid and 
destained in water. The membrane was blocked overnight 
at 4°C with bovine serum albumin (3% w/v). The blot was 
washed with Tris buffered saline (25 mM, pH 8.0) 
containing 0.05% Tween 20 and 0.1% BSA and incubated 
with IgG fraction of rabbit anti TPST antibody for an hour 
at room temperature. After washing the blot with wash 
buffer, the membrane was further incubated with alkaline 
phosphatase conjugated goat anti-rabbit immunoglobulin 
G (1:5000) for an hour. The substrate for alkaline 
phosphatase was consisted of the p-nitro blue tetrazolium 
and 5-bromo-4-chloro-3-indolyl phosphate.  
Immunoprecipitation 
Immunoprecipitation of the TPST present in saliva 
was carried out in 1.5 ml microcentrifuge tubes using 
TPST antibody, as described in [1]. Briefly, different 
concentrations of immune and preimmune sera (1:1000 
dilution) were added to 100 µl of saliva and the mixture 
was incubated at room temperature for 4 h. After 
incubation, 30 µl of Protein A sepharose (25%) was added. 
Following overnight agitation at 4°C, Protein A sepharose 
beads bound to antigen-antibody complexes were pelleted 
by centrifugation and the supernatant was used for TPST 
assay.  
Purification of tyrosylprotein Sulfotransferase from 
saliva by Immuno affinity Chromatography 
The IgG fraction of rabbit anti-TPST was coupled to 
CNBr-activated Sepharose 4B beads. About 75 mg of IgG 
fraction was coupled to 7.5 ml CNBr-Sepharose 4B as 
described earlier [22] and the beads were stored at 4oC 
with addition of preservative. The amount of protein 
coupled to beads was measured by estimating protein in 
the supernatant before and after coupling. Two ml beads 
were packed in a mini column and equilibrated with 20 
mM MES pH 6.8. Five ml volumes of saliva was applied to 
the affinity column and equilibrated for 30 min. The 
column was washed with 10 volumes of equilibration 
buffer. The bound enzyme was eluted with Gly-HCl 
buffer pH 2.7 and pH was raised immediately with 1.0 M 
Tris. The fractions were further tested for the presence of 
enzyme by dot blotting. The enzyme activity was assayed 
and the purity of the enzyme was examined staining the 
polyacrylamide gels with silver.  
3.  Results 
Characterization of TPST 
The presence of tyrosylprotein sulfotransferase 
activity was observed in human saliva using EAY as 
sulfate acceptor and [35S] PAPS as sulfate donor. The clear 
supernatant of normal and parotid saliva showed TPST 
activity. The tyrosine sulfation increased proportionately 
with increasing concentrations of saliva protein up to 25 
µg (Figure 1). The enzyme activity increased with 
increased incubation time up to 30 min and reached its 
maximum at 60 min (Figure 2). The effect of pH on the 
EAY sulfation by human whole saliva and parotid saliva 
are shown in Figure 3. Using the MES buffer, the pH 
optimum for the sulfation of EAY by the two enzymes 
was found to be 6.8 and significant activity was also 
observed in parotid saliva at pH 5.5. In the absence of 
MnCl2, minimal sulfation of EAY was detected. Optimum 
enzyme activity was detected at 20 mM MnCl2 (Figure 4) 
The direct effect of increasing concentrations 
(0.025%-0.25%) of Triton X-100 concentrations on the 
activity of tyrosylprotein sulfotransferase was studied. No 
change in the enzyme activity was observed at various 
concentrations of Triton X-100 (data not shown). Since the 
enzyme present in saliva was not membrane bound, 
tyrosylprotein sulfotransferase sulfation of EAY was not 
altered in the presence of detergent. Requirements of 
metal ions for tyrosylprotein sulfotransferase of human 
whole saliva is given in Table 1. Of the metals examined at 
20 mM, Mn2+ and Ca2 w e r e  a b l e  t o  s t i m u l a t e  
tyrosylprotein sulfotransferase activity, where as Mg2+ 
exhibited around 50% of the stimulation attained with 
Mn2+ and EDTA inhibited the enzyme activity.  
Immunoprecipitation 
The polyclonal TPST antibodies were also tested for 
their ability to immunoprecipitate the TPST in the saliva. 
Antibodies were incubated with the saliva and coupled to 
protein A Sepharose beads. After centrifugation, presence 
of the TPST activity was determined in the supernatant by 
e n z y m e  a s s a y .  A s  s h o w n  i n  F i g u r e  5 ,  w i t h  i n c r e a s i n g  
concentration of TPST antiserum in the 
immunoprecipitated sample, the supernatant showed 
decreased TPST activity. Almost 80% of the activity was 
immunoprecipitated with 50 µl of a 1:1000 dilution of 
antiserum, when compared with the preimmune serum. 
Purification of TPST from Human saliva 
Purification of TPST to homogeneity from saliva was 
achieved by immunoaffinity column chromatography. 
This method resulted in a 25, 071-fold increase in tyrosine 
sulfating activity (Table 2). The purified enzyme exhibited 
protein band of 50-54 kDa on SDS-PAGE (Figure 6A) and 
on immunoblots (Figure 6B) similar to the enzyme 
obtained from submandibular salivary glands [1]. The 3, 
389-fold purification of tyrosine sulfating activity from 
human saliva to near homogeneity (Table 2) differs from Int. J. Biol. Sci. 2005 1  143
the 140, 000 and 25, 358-fold purification required for 
adrenal and rat submandibular salivary gland enzyme, 
respectively, suggesting that saliva represent a better 
enriched source of this enzyme. 
4.  Discussion 
Sulfation represents an important mechanism in vivo 
for the biotransformation and excretion of a variety of 
proteins. Upon sulfation some proteins undergo changes 
in their biological activities to fulfill particular biochemical 
and physiological needs. Since the first description of a 
TPST activity, the enzyme has been reported in various 
tissues in bovine adrenal medulla [14], rat [15], and PC12 
cells [23]. However, there are no reports of its presence in 
secretion. In this paper, the existence of tyrosylprotein 
sulfotransferase activity was demonstrated in human 
whole saliva and parotid saliva using 35S-PAPS as co-
substrate for sulfation. Using the acidic, synthetic 
polymer, poly Glu6, Ala3, Tyr1 (EAY), Domiano and Roth 
[15] demonstrated a fairly wide-tissue distribution of 
tyrosylprotein sulfotransferase in the rat. Later, Sundaram 
[18] have characterized the enzyme present in the rat 
submandibular salivary glands. Some of the properties of 
human salivary tyrosylprotein sulfotransferase described 
here appear to be similar to those reported earlier for this 
enzyme in other rat tissues. As shown in the Figure 4, the 
human salivary tyrosylprotein sulfotransferase exhibited 
optimum pH at 6.8, which is similar to sulfotransferase 
reported in rat submandibular salivary glands [18] and 
other rat tissues [15,17]. However, the enzyme isolated 
from rat submandibular salivary glands displayed pH 
optimum of 6.2 [18] and the pH optimum observed for rat 
brain was 5.8 [24]. The solubilized enzyme from adrenal 
medulla has a pH optimum between 6.0 and 6.5 [14]. 
Human salivary tyrosylprotein sulfotranferase activity 
was stimulated by the divalent cations Mn2+, Ca2+ and 
partially by Mg2+ and was inhibited by EDTA. The 
enzymatic activity mediating the sulfation of proteins in 
PC12 cell was stimulated by the presence of Mg2+ and 
Mn2+ and inhibited by EDTA [14]. Both Mn2+ and Mg2+ 
were equally effective in activating EAY sulfation by 
bovine adrenal medulla [14] and rat cerebral cortex [16], 
where as Mn2+ and Co2+ stimulated rat liver tyrosylprotein 
sulfotrasferase [15]. In contrast, sulfation of an 
endogenous membrane protein in A431 cell was not 
inhibited by EDTA [25]. 
Antibodies raised against the tyrosylprotein 
sulfotransferase from rat submandibular salivary glands 
recognized the enzyme present in the saliva and the 
antibody was also capable of immunoprecipitating the 
enzyme activity in saliva. SDS-PAGE analysis of salivary 
tyrosylprotein sulfotransferase isolated from antibody 
column revealed a protein of 50-54 kDa in silver stained 
gels. A similar 50-54 kDa protein was observed for TPST 
purified from bovine adrenal medulla [26], rat liver [22] 
and submandibular salivary glands [1]. 
5.  Summary 
We have identified TPST in human saliva in addition 
to our earlier reports on its presence in submandibular 
salivary glands [1]. Although the enzyme activity 
responsible for tyrosine sulfation was demonstrated 
several decades ago, very little is known about the 
function of tyrosine sulfation, particularly, in salivary 
metabolism. The better understanding of this process 
needs further studies involving the identification of 
salivary proteins that are candidates for tyrosine sulfation. 
In naturally occurring substrates of tyrosylprotein 
sulfotransferase, the sulfated tyrosyl residues are 
predominantly surrounded by acidic amino acids [27,28]. 
These studies suggest that acidic environments are the 
important determinants for tyrosine sulfation. Salivary 
statherin is a 43-residue polypeptide which is tyrosine-
rich and contains 7 tyrosine residues. The peptide also 
contains a sequence E-Q-P-L-Y (residues 26-30) suggested 
for tyrosine sulfation [28,29]. The availability of TPST and 
antibody will facilitate well-defined studies on the role of 
this important function in saliva in physiological and 
pathological conditions.  
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Tables & Figures 
Table 1: Requirements for Human Salivary Tyrosylprotein 
Sulfotransferase Activity. 
Divalent cation 10 (mM)  Tyrosylprotein Sulfotransferase 
(pmol/mg/30 min) 
MnCl2 12.4  ± 1.7 
CaCl2 9.7  ± 1.4 
MgCl2 5.6  ± 1.3 
EDTA 1.9  ± 0.7 
Enzyme activities were measured as described under Materials and Methods. 
Values are the mean ± SE of three experiments. 
 Table 2. Comparison of TPST properties 
Property Submandiblular  salivary 
gland TPST 
Saliva TPST 
Mol. Wt (kDa)  55  55 
pH optimum  6.2-6.8  6.8 
Additives: 
MnCl2 (mM) 
Triton X-100 
20 
Increase in activity 
20 
No increase in 
activity 
Spec. Activity* of 
unpurified TPST 
2.1 12.3 
Spec. Activity* of 
purified TPST 
 
53250 
 
41670 
Purification fold  25358  3389 
* (pmol/mg/30 min) 
Figure 1. Tyrosine sulfation activity of human whole saliva as a 
function of protein concentration. The tyrosylprotein 
sulfotransferase activity was measured as described under 
Materials and Methods except that the protein concentration was 
varied.  
 
Figure 2. Tyrosine sulfation activity of human whole saliva as a 
function of time. The tyrosylprotein sulfotransferase activity 
was measured as described under Materials and Methods except 
that reaction time was varied. 
 
  Figure 3. Effect of pH on the activity of tyrosylprotein 
sulfotransferase of human whole saliva (•) and parotid saliva 
(♦). The tyrosylprotein sulfotransferase activity was measured 
as described under Materials and Methods except that the pH of 
the assay buffer was varied. 
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Figure 4. Effect of MnCl2 on tyrosylprotein sulfotransferase of 
human whole saliva. The composition of the assay medium was 
described under Materials and Methods except that MnCl2 
concentration was varied from 0 to 30 mM.  
 
Figure 5. Immunoprecipitation with anti-TPST antiserum. The 
indicated amounts of anti-TPST antiserum were incubated in a 
final volume of 100µl with human saliva. The mixtures were 
further treated and the supernatants assayed for tyrosylprotein 
sulfotransferase activity as described under Materials and 
Methods.  
 
Figure 6. Western blot analysis of purified tyrosylprotein 
sulfotransferase. The immunoblot analysis was carried out as 
described under Materials and Methods. Identification of TPST 
purified from whole saliva by silver staining (Lane A) and by 
western blot (Lane B).  
 
 
 
 
 